Alex Zwye is the founder of NLS Pharma. NLS Pharma has raised $3M in total funding. Latest round: Series B. Backed by Kadimastem.
Alex Zwyer is the CEO and Executive Board Member of NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company. NLS Pharmaceutics focuses on developing therapies for central nervous system disorders. The company is currently engaged in a merger with Kadimastem Ltd., a clinical-stage cell therapy company, which upon completion, will form NewcelX.
Full founder directory · Investor directory · Company funding database · Fundraising library